First-line treatment outcomes according to cfDNA analysis of RAS mutation status in metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study
- García Alfonso, P. 1
- Valladares-Ayerbes, M. 2
- Muñoz Luengo, J. 3
- Pimentel, P. 4
- Viéitez, J.M. 5
- Cruz Hernandez, J.J. 6
- Llanos, M. 7
- Garcia Girón, C. 8
- Salud Salvia, A. 9
- Lloansí Vila, A. 10
-
1
Hospital General Universitario Gregorio Marañón
info
-
2
Instituto de Salud Carlos III
info
-
3
Hospital San Pedro de Alcántara
info
- 4 Medical Oncology Department, Hospital General Universitario Santa Lucia
-
5
Hospital Universitario Central de Asturias
info
-
6
Hospital Universitario de Salamanca
info
-
7
Hospital Universitario de Canarias
info
-
8
Complejo Asistencial Universitario de Burgos
info
-
9
Hospital Arnau de Vilanova
info
- 10 Medical Oncology Department, Amgen S.A.
Journal:
Annals of oncology : official journal of the European Society for Medical Oncology
ISSN: 1569-8041
Year of publication: 2018
Volume: 29
Pages: viii183
Type: Article
DOI:
10.1093/annonc/mdy281.092
PMID:
32136350
SCOPUS:
2-s2.0-85081528607
GOOGLE SCHOLAR
lock_openOpen access editor
Data source: Scopus